Associated Papers
Different prognostic impact of STK11 mutations in non-squamous non-small-cell lung cancer.
Pécuchet N et al.
Oncotarget, 2017
26625312 (PubMed )
Supplement: oncotarget-08-23831-s002.xls › Feuil1
Toward the molecular dissection of peritoneal pseudomyxoma.
Pietrantonio F et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology, 2016
GNAS mutations as prognostic biomarker in patients with relapsed peritoneal pseudomyxoma receiving metronomic capecitabine and bevacizumab: a clinical and translational study.
Pietrantonio F et al.
Journal of Translational Medicine, 2016
Select a paper to view details